| Prediction of true positive lung cancer in abnormal suspicious CT lung screens |
Martin Tammemagi |
Henry Ford Health System |
NLST |
May 17, 2011 |
201105-0015 |
| Genome-wide Association Study of Benign Prostatic Hyperplasia |
Sonja Berndt |
NCI, DCEG, OEEB |
PLCO |
Apr 20, 2011 |
2011-0078 |
| Coffee, tea, caffeine and the risk of cancer |
Mia Hashibe |
University of Utah |
PLCO |
Apr 4, 2011 |
2011-0052 |
| Prostate cancer risk in relation to obesity and diabetes: A pooled analysis (Cohort Consortium Study) |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Mar 25, 2011 |
2011-0053 |
| KIR/HLA/MIR148A variation and risk of prostate cancer |
Stella Koutros |
NCI, DCEG, OEEB |
PLCO |
Mar 9, 2011 |
2011-0039 |
| Mitochondrial DNA Copy Number and Prostate Cancer Risk |
Sonja Berndt |
NCI, DCEG, OEEB |
PLCO |
Mar 9, 2011 |
2011-0037 |
| Risk of multiple myeloma in relation to plasma adipokine levels: a nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Jonathan Hofmann |
DCEG - Other |
PLCO |
Mar 9, 2011 |
2011-0028 |
| Prostate Cancer Survival in PLCO: The effect of screening |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Mar 3, 2011 |
2010-0301 |
| Risk factors for endometrial cancer in black and white women in the Epidemiology of Endometrial Cancer Consortium (E2C2) |
Sara Olson |
Memorial Sloan-Kettering Cancer Center |
PLCO |
Feb 2, 2011 |
2010-0290 |
| Oxford Pooling Project: Prostate (endogenous hormones and nutritional biomarkers) |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Jan 31, 2011 |
2010-0320 |
| Inflammatory Markers and Subsequent Risk of Prostate Cancer |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jan 20, 2011 |
2010-0034 |
| CT Individual Dose Project |
Randell Kruger |
Marshfield Clinic Research Foundation |
NLST |
Dec 28, 2010 |
201012-0028 |
| Side-effects and complications of prostate biopsies, radical prostatectomies and prostate cancer diagnoses within the PLCO Trial |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Nov 23, 2010 |
2010-0265 |
| Arylamine hemoglobin (Hgb)-adducts and bladder cancer risk in never-smokers within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) |
Jonine Figueroa |
NCI |
PLCO |
Nov 22, 2010 |
2010-0113 |
| Variability Among NLST Radiologists |
Paul Pinsky |
National Cancer Institute |
NLST |
Nov 19, 2010 |
201011-0010 |
| Inflammation markers and risk of endometrial and ovarian cancer |
Nicolas Wentzensen MD |
NCI |
PLCO |
Nov 18, 2010 |
2010-0211 |
| Inflammatory Markers and Smoking-Associated Cancers |
Meredith Shiels |
NCI |
PLCO |
Nov 18, 2010 |
2010-0201 |
| Prospective Oral HPV Detection and Risk of Head and Neck Cancers |
Ilir Agalliu |
Other (Specify) |
PLCO |
Nov 18, 2010 |
2010-0153 |
| Estimation of sensitivity of chest x-ray and cancer preclinical sojourn time for the lung component of the PLCO trial |
Ping Hu |
NCI, DCP, BRG |
PLCO |
Oct 22, 2010 |
2010-0076 |
| Estimation of Mean Sojourn and Lead Time and Sensitivity in the Ovarian Component of the PLCO Trial |
Jian-Lun Xu |
NCI, DCP, BRG |
PLCO |
Oct 22, 2010 |
2010-0077 |
